Literature DB >> 25412733

Lupus and leprosy: beyond the coincidence.

F M Ribeiro1, V E Gomez, E M N Albuquerque, E M Klumb, Y Shoenfeld.   

Abstract

Systemic lupus erythematous (SLE) is an autoimmune disease that presents an increased susceptibility to infections which may trigger reactivation. Disease flares have been mostly associated with parvovirus B19, cytomegalovirus, EBV and Mycobacterium tuberculosis infections, but it is probable that many other agents may also induce innate and adaptive immune system stimulation including the production of autoantibodies as ANA, anti nDNA and anti-ß2-GPI mainly in lepromatous leprosy. Mycobacterium leprae not only may determine symptoms that mimic lupus flares, including autoantibodies production, but could also act as a trigger for lupus reactivation; however, its association is still not fully explored. As demonstrated for tuberculosis, it is quite possible that molecular mimicry may also be involved in the interface of these two diseases. Some studies reported shared epitopes among idiotypes derived from 8E7 and TH9 lepromatous antibodies and those obtained from SLE patients, and it could partially explain the triggering phenomenon of SLE caused by M. leprae. We report and discuss three Brazilian patients whose disease was inactive and presented disease flares concurrently with the diagnosis of leprosy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25412733     DOI: 10.1007/s12026-014-8596-y

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  36 in total

Review 1.  Interaction of dendritic cells with mycobacteria: where the action starts.

Authors:  C Demangel; W J Britton
Journal:  Immunol Cell Biol       Date:  2000-08       Impact factor: 5.126

2.  Global leprosy situation, 2010.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2010-08-27

Review 3.  Infections and SLE.

Authors:  Gisele Zandman-Goddard; Yehuda Shoenfeld
Journal:  Autoimmunity       Date:  2005-11       Impact factor: 2.815

Review 4.  Leprosy. An update: definition, pathogenesis, classification, diagnosis, and treatment.

Authors:  K Eichelmann; S E González González; J C Salas-Alanis; J Ocampo-Candiani
Journal:  Actas Dermosifiliogr       Date:  2013-07-17

5.  Exacerbation of systemic lupus erythematosus related to cytomegalovirus infection.

Authors:  T Hayashi; S Lee; H Ogasawara; I Sekigawa; N Iida; Y Tomino; H Hashimoto; S Hirose
Journal:  Lupus       Date:  1998       Impact factor: 2.911

Review 6.  Mycobacteria and autoimmunity.

Authors:  Y Shoenfeld; D A Isenberg
Journal:  Immunol Today       Date:  1988-06

7.  Comparison between autoantibodies in malaria and leprosy with lupus.

Authors:  E Bonfa; R Llovet; M Scheinberg; J M de Souza; K B Elkon
Journal:  Clin Exp Immunol       Date:  1987-12       Impact factor: 4.330

8.  Antiphospholipid antibodies in leprotic patients: a correlation with disease manifestations.

Authors:  A Elbeialy; K Strassburger-Lorna; T Atsumi; M L Bertolaccini; O Amengual; M Hanafi; M A Khamashta; G R Hughes
Journal:  Clin Exp Rheumatol       Date:  2000 Jul-Aug       Impact factor: 4.473

9.  Monoclonal anti-tuberculosis antibodies react with DNA, and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis.

Authors:  Y Shoenfeld; Y Vilner; A R Coates; J Rauch; G Lavie; D Shaul; J Pinkhas
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

10.  Epidemiologic characteristics of leprosy reactions.

Authors:  D M Scollard; T Smith; L Bhoopat; C Theetranont; S Rangdaeng; D M Morens
Journal:  Int J Lepr Other Mycobact Dis       Date:  1994-12
View more
  5 in total

1.  Hyperjaponol H, A New Bioactive Filicinic Acid-Based Meroterpenoid from Hypericum japonicum Thunb. ex Murray.

Authors:  Rongrong Wu; Zijun Le; Zhenzhen Wang; Shuying Tian; Yongbo Xue; Yong Chen; Linzhen Hu; Yonghui Zhang
Journal:  Molecules       Date:  2018-03-18       Impact factor: 4.411

Review 2.  Viruses and Autoimmunity: A Review on the Potential Interaction and Molecular Mechanisms.

Authors:  Maria K Smatti; Farhan S Cyprian; Gheyath K Nasrallah; Asmaa A Al Thani; Ruba O Almishal; Hadi M Yassine
Journal:  Viruses       Date:  2019-08-19       Impact factor: 5.048

3.  Leprosy detection rate in patients under immunosuppression for the treatment of dermatological, rheumatological, and gastroenterological diseases: a systematic review of the literature and meta-analysis.

Authors:  Daniel Holanda Barroso; Jurema Guerrieri Brandão; Elaine Silva Nascimento Andrade; Ana Clara Banhatto Correia; Danielle Costa Aquino; Ana Carolina Rios Chen; Sebastian Vernal; Wildo Navegantes de Araújo; Lícia Maria Henrique da Mota; Raimunda Nonata Ribeiro Sampaio; Patrícia Shu Kurizky; Ciro Martins Gomes
Journal:  BMC Infect Dis       Date:  2021-04-13       Impact factor: 3.090

Review 4.  CD4+ Cytotoxic T Cells Involved in the Development of EBV-Associated Diseases.

Authors:  Manuel Ruiz-Pablos
Journal:  Pathogens       Date:  2022-07-25

5.  Household Contacts of Leprosy Patients in Endemic Areas Display a Specific Innate Immunity Profile.

Authors:  Anouk van Hooij; Maria Tió-Coma; Els M Verhard; Marufa Khatun; Khorshed Alam; Elisa Tjon Kon Fat; Danielle de Jong; Abu Sufian Chowdhury; Paul Corstjens; Jan Hendrik Richardus; Annemieke Geluk
Journal:  Front Immunol       Date:  2020-08-11       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.